1 St Source Bank Bristol Myers Squibb CO Transaction History

1 St Source Bank

$1.77 Billion
Q3 2024

A detailed history of 1 St Source Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, 1 St Source Bank holds 30,007 shares of BMY stock, worth $1.73 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

30,007

Previous 31,753 5.5%

Holding current value

$1.73 Million

Previous $1.32 Million 17.75%

% of portfolio

0.09%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 11, 2024	SELL	$39.66 - $51.75 $69,246 - $90,355	-1,746 Reduced 5.5%	30,007 $1.55 Million
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $143,893 - $189,439	-3,575 Reduced 10.12%	31,753 $1.32 Million
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $222,579 - $252,361	-4,639 Reduced 11.61%	35,328 $1.92 Million
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $58,272 - $69,535	-1,202 Reduced 2.92%	39,967 $2.05 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $7,583 - $8,479	-131 Reduced 0.32%	41,169 $2.39 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $112,957 - $125,422	-1,773 Reduced 4.12%	41,300 $2.64 Million
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $5,848 - $6,633	-89 Reduced 0.21%	43,073 $2.99 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $59,783 - $70,791	-873 Reduced 1.98%	43,162 $3.11 Million
Q3 2022 Nov 04, 2022	SELL	$0.13 - $76.84 $20 - $12,140	-158 Reduced 0.36%	44,035 $3.13 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $84,820 - $93,416	-1,168 Reduced 2.57%	44,193 $3.4 Million
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $15,738 - $18,872	256 Added 0.57%	45,361 $3.31 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $4,933 - $5,751	-92 Reduced 0.2%	45,105 $2.81 Million
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $11,656 - $13,654	-197 Reduced 0.43%	45,197 $2.67 Million
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $39,189 - $42,676	633 Added 1.41%	45,394 $3.03 Million
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $104,735 - $117,796	-1,765 Reduced 3.79%	44,761 $2.83 Million
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $723,655 - $820,034	-12,533 Reduced 21.22%	46,526 $2.89 Million
Q3 2020 Oct 30, 2020	SELL	$57.43 - $63.64 $33,366 - $36,974	-581 Reduced 0.97%	59,059 $3.56 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $55,806 - $65,243	1,018 Added 1.74%	59,640 $3.51 Million
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $28,072 - $40,795	-605 Reduced 1.02%	58,622 $3.27 Million
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $35,480 - $46,280	721 Added 1.23%	59,227 $3.8 Million
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $283,180 - $335,750	-6,621 Reduced 10.17%	58,506 $2.97 Million
Q2 2019 Jul 29, 2019	BUY	$44.62 - $49.34 $115,431 - $127,642	2,587 Added 4.14%	65,127 $2.95 Million
Q1 2019 Apr 29, 2019	SELL	$45.12 - $53.8 $189,684 - $226,175	-4,204 Reduced 6.3%	62,540 $2.98 Million
Q4 2018 Feb 11, 2019	BUY	$48.76 - $63.23 $18,285 - $23,711	375 Added 0.57%	66,744 $3.47 Million
Q3 2018 Oct 31, 2018	SELL	$55.19 - $62.25 $8,278 - $9,337	-150 Reduced 0.23%	66,369 $4.12 Million
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $244,262 - $304,445	-4,834 Reduced 6.77%	66,519 $3.68 Million
Q1 2018 Apr 24, 2018	BUY	$59.92 - $68.98 $30,978 - $35,662	517 Added 0.73%	71,353 $4.51 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $37,942 - $41,366	-633 Reduced 0.89%	70,836 $4.34 Million
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $3.95 Million - $4.56 Million	71,469	71,469 $4.56 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1 St Source Bank, based on Form 13F filings with the SEC.

News

Stay updated on 1 St Source Bank with notifications on news.

Account